MedTrace Logo

Levocetirizine Effect on Nasal Nitric Oxide and Nasal Eosinophils in Subjects With Perennial Allergic Rhinitis

NCT00894231 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2009-09-04

No results posted yet for this study

Summary

The purpose of this study is to noninvasively measure the anti-inflammatory effect of levocetirizine after two weeks of treatment in allergic rhinitis subjects.

Conditions

  • Perennial Allergic Rhinitis

Interventions

DRUG

levocetirizine (Xyzal)

5mg po QD

DRUG

placebo

sugar tablet

Sponsors & Collaborators

  • UCB Pharma

    collaborator INDUSTRY

  • AAADRS Clinical Research Center

    lead OTHER

Principal Investigators

  • Miguel J Lanz, MD · AAADRS Clinical Research Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
12 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2009-08-31
Completion
2009-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00894231 on ClinicalTrials.gov